当着夫的面被夫上司玩弄,最近免费中文字幕中文高清百度 ,超碰CAOPORON入口,精品国产日韩一区二区三区

上海莼試生物技術有限公司

主營產品: ELISA試劑盒,ELISA試劑盒價格,ELISA試劑盒報價

8

聯(lián)系電話

13585831301

您現(xiàn)在的位置: 上海莼試生物技術有限公司>>生化試劑>>其它生化試劑>> 1304-85-4價格

公司信息

聯(lián)人:
李小姐
話:
021-59541103
機:
13585831301
售后電話:
13585831301
真:
021-60443211
址:
上海市嘉定區(qū)嘉羅公路1661號
編:
址:
鋪:
http://www.yixinui.com/st562820/
給他留言
1304-85-4價格
1304-85-4價格
參考價 面議
具體成交價以合同協(xié)議為準
  • 型號
  • 品牌
  • 廠商性質 經銷商
  • 所在地 上海市

更新時間:2017-07-22 12:57:43瀏覽次數(shù):261

聯(lián)系我們時請說明是環(huán)保在線上看到的信息,謝謝!

【簡單介紹】
1304-85-4價格避光、干燥陰涼處封閉貯存,嚴禁與有毒、有害物品混放、混運。本品為非危險 產品可按一般化學品運輸,輕搬動輕放,防止日曬、雨淋!受熱、受潮、受光后易喪失活力,保存期短,因此貯存和運輸條件比較苛刻。?

1304-85-4價格其他中文名稱: 堿式硝酸氧化鉍;;硝酸氧鉍;西班牙白;次硝蒼;堿性硝酸鉍 
英文名稱: Bismuth subnitrate 
其他英文名稱: Bismuth nitrate basic;Bismuth(III) nitrate basic;Bismuth(III) oxynitrate;Bismuth(III) subnitrate 
產品規(guī)格: AR,79% 
包裝:100克/500克
:1304-85-4
Bi5H9N4O22=1461.99
級別:AR
含量:79.0~82.0%
氯化物:≤0.005%
硫酸鹽:≤0.01%
鐵:≤0.003%
銅:≤0.005%
砷:≤0.0006%
鉛:≤0.05%
銀:≤0.003%
硝酸不溶物:≤0.005%
硫化氫不沉淀物:≤0.25%
澄清度試驗:≤4號
性狀:重質粉末。無氣味。無味。對光敏感。微有吸濕性。系堿式鹽,因制備方法不同而有各種不同組成,含70%~74%Bi或79%~82%Bi2O3 。溶于鹽酸、硝酸、稀硫酸和濃乙酸,幾乎不溶于水和乙醇。灼燒分解成氧化鉍和氧化氮。相對密度4.928。熔點260℃(分解)。有刺激性。
用途:生化研究。臨床檢驗中用以檢驗糖和生物堿。鉍鹽、陶釉
保存:RT,避光

1304-85-4價格儲存條件: 避光、干燥陰涼處封閉貯存,嚴禁與有毒、有害物品混放、混運。本品為非危險 產品可按一般化學品運輸,輕搬動輕放,防止日曬、雨淋!受熱、受潮、受光后易喪失活力,保存期短,因此貯存和運輸條件比較苛刻。

產品名稱英文名稱價格

 Bismuth 

 1304-85-4

電詢
 

要優(yōu)級純、分級純和化學純3種:
(1)優(yōu)級純(GR:Guaranteed reagent),又稱一級品或保證試劑,99.8%,這種試劑純度zui高,雜質含量zui低,適合于重要精密的分析工作和科學研究工作,使用綠色瓶簽。 
(2)分析純(AR),又稱二級試劑,純度很高,99.7%,略次于優(yōu)級純,適合于重要分析及一般研究工作,使用紅色瓶簽。 
(3)化學純(CP),又稱三級試劑,≥ 99.5%,純度與分析純相差較大,適用于工礦、學校一般分析工作。使用藍色(深藍色)標簽。 
(4)實驗試劑(LR:Laboratory reagent),又稱四級試劑。
公司提供的優(yōu)級純,分析純,化學純,試劑級,基準試劑,實驗純,教學試劑,高純試劑,色譜純,光譜純,電子純。各種包裝規(guī)格,并可提供包裝定制,咨詢訂購。

乙酸鋰6108-17-4價格點:
1,全:公司提供上萬種產品,涵蓋了生物試劑,elisa試劑盒,標準品,培養(yǎng)基,原裝耗材等,基本上各種科研所需產品在我司都能找到。 
2,新:產品更新速度較快,基本上每周都有新產品出現(xiàn)。
3,優(yōu):產品質量好,*。
4,品牌多:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等國內外 
5.售后:我公司具有優(yōu)質的技術團隊,產品一旦售出,實驗過程中遇到困難可提供在線技術咨詢。使您使用產品時沒有任何的后顧之憂。 
氫溴酸樟柳堿(100 99
(5889
(100050
(100049
(100 09
琥珀酸鈉(100 62
(100152
芹菜甙元-7- 葡萄糖甙(5 64
茄尼醇(58 2
(1004 0
茜素雙酯(100418
前列腺素E1(5845
前列腺素(5844
前列腺環(huán)素(5846
鉛079802
千里光寧(58 5
千金子二萜醇 
千金藤素;頭花千金藤堿(5709
氣相色譜儀檢定和測試用標準物質1 0229
氣相色譜儀檢定和測試用標準物質1 02 2
氣相色譜儀檢定和測試用標準物質1 02 1
氣相色譜儀檢定和測試用標準物質1 02 0
(100 46
鐠Pr(GSBG62049-90
(100  2
(100082
葡聚糖酶(D044 -50ml
葡聚糖硫酸鈉鹽(5800
(100  1
龍(10015 
(10008 
鈹Be(GSBG62002-90
硼酸-無貨0798 0
諾米林(5854
諾卡酮(+(5761
成分分析標準物質(80 5
釹Nd(GSBG62050-90
牛蒡子苷 
檸檬烯(芋烯(100470

(S)-3-(4-methoxyphenyl)-N-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)propanamido)prop*; PR-957
N-methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-(pyridin-2-yl)phenyl)acetamide
N-methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-(pyridin-2-yl)phenyl)acetamide
Ac-His-Pro-Phe-Val-Statine-Leu-Phe-NH
Ac-His-Pro-Phe-Val-Statine-Leu-Phe-NH
trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]- cyclohexanecarboxylic acid; LY2484595
trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]- cyclohexanecarboxylic acid; LY2484595
5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide
5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide
N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide
N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole
1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol
1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol
N-cyclopropyl-5-(2-thienyl)-3-isoxazolecarboxamide
N-cyclopropyl-5-(2-thienyl)-3-isoxazolecarboxamide
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, methyl, 1-methylester diester
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, methyl, 1-methylester diester
2-(4-Benzylphenoxy)-N-(1-benzylpiperidin-4-yl)acetamide
2-(4-Benzylphenoxy)-N-(1-benzylpiperidin-4-yl)acetamide
((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentylmethyl sulfamate
((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentylmethyl sulfamate
(2S,3R,4R,6E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid
(2S,3R,4R,6E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, methyl, 1-methylester diester
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid, methyl, 1-methylester diester
N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid
N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid
3,5-Bis[(4-methylphenyl)methylene]-4-piperidone hydrochloride
3,5-Bis[(4-methylphenyl)methylene]-4-piperidone hydrochloride
(2S, 3S)-2-Amino-3 –methyl-1-(thiazolidin-3-yl)pentan-1-one hemi-fumarate
(2S, 3S)-2-Amino-3 –methyl-1-(thiazolidin-3-yl)pentan-1-one hemi-fumarate
2-(4-Benzylphenoxy)-N-(1-benzylpiperidin-4-yl)acetamide, hydrochloride
2-(4-Benzylphenoxy)-N-(1-benzylpiperidin-4-yl)acetamide, hydrochloride
4-(tert-Butyl)-N-(3-(4-(4-methoxybenzyl)piperazin-1-yl)-3-oxopropyl)benzamide
4-(tert-Butyl)-N-(3-(4-(4-methoxybenzyl)piperazin-1-yl)-3-oxopropyl)benzamide
N6-Methyl-(R)-roscovitine; Amyloid-β Forty-Two Inducer 4
N6-Methyl-(R)-roscovitine; Amyloid-β Forty-Two Inducer 4
(2R)-2-[[9-Isopropyl-6-(N-methylanilino)purin-2-yl]amino]butan-1-ol; Amyloidβ Forty-Two Inducer 5
(2R)-2-[[9-Isopropyl-6-(N-methylanilino)purin-2-yl]amino]butan-1-ol; Amyloidβ Forty-Two Inducer 5
Methylenesuccinic acid; 2-Propene-1,2-dicarboxylic acid
Methylenesuccinic acid; 2-Propene-1,2-dicarboxylic acid
4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid
4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid
GSK-2830371
GSK-2830371
Aminooxoacetic acid sodium salt, Oxalic acid monoamide sodium salt, Oxamic acid sodium salt
Aminooxoacetic acid sodium salt, Oxalic acid monoamide sodium salt, Oxamic acid sodium salt
Nordihydroguaiaretic Acid; 4,4’-(2,3-dimethyl-1,4-butanediyl)bis-1,2-benzenediol
Nordihydroguaiaretic Acid; 4,4’-(2,3-dimethyl-1,4-butanediyl)bis-1,2-benzenediol
N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine[egr]1-lactone; LY 146032
N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine[egr]1-lactone; LY 146032
1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0; L 743872; MK 0991)
1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0; L 743872; MK 0991)
Sodium Pneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl]-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-
Sodium Pneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl]-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-
6,6-[(3,3’-Dimethyl[1,1’-biphenyl]-4,4’-diyl)bis(azo)bis[4-amino- 5-hydroxy-1,3-naphthalenedisulphonic acid] tetrasodium salt
N2-1H-Benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine
N2-1H-Benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine
4,4-Difluoro-8-(4-ethynylphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene
4,4-Difluoro-8-(4-ethynylphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene
6-N-[2-[[4-(2,4-dichlorophenyl)-5-imidazol-1-ylpyrimidin-2-yl]amino]ethyl]-3-nitropyridine-2,6-diamine; CT 98014
6-N-[2-[[4-(2,4-dichlorophenyl)-5-imidazol-1-ylpyrimidin-2-yl]amino]ethyl]-3-nitropyridine-2,6-diamine; CT 98014
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide; AAE581
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide; AAE581
(S)-8-chloro-2-(pyrrolidin-2-yl)benzofuro[3,2-d]pyrimidin-4(3H)-one
(S)-8-chloro-2-(pyrrolidin-2-yl)benzofuro[3,2-d]pyrimidin-4(3H)-one
N1-(4-chlorophenyl)-6-methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]- 1,5-Isoquinolinediamine
N1-(4-chlorophenyl)-6-methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]- 1,5-Isoquinolinediamine
4-(4-((4-((3-acrylamidophenyl)amino)-5-fluoropyrimidin-2-yl)amino)phenoxy)-N-methylpicolinamide
4-(4-((4-((3-acrylamidophenyl)amino)-5-fluoropyrimidin-2-yl)amino)phenoxy)-N-methylpicolinamide
Cyclohexyl 1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-3-quinolinecarboxylate
Cyclohexyl 1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-3-quinolinecarboxylate
[4-[[5-Chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinylmethanone
[4-[[5-Chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinylmethanone
[N-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine
[N-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine

 



產品對比 二維碼 在線交流

掃一掃訪問手機商鋪

對比框

在線留言
沅陵县| 望城县| 磐安县| 永川市| 平利县| 诸暨市| 平陆县| 临安市| 双鸭山市| 武义县| 乌兰察布市| 通辽市| 治多县| 滨州市| 科尔| 临武县| 大石桥市| 黄平县| 黄骅市| 西华县| 苏尼特左旗| 陆川县| 泗洪县| 确山县| 安溪县| 贵阳市| 平果县| 遂溪县| 平武县| 武宣县| 凌云县| 郓城县| 肥东县| 喀什市| 教育| 垣曲县| 长武县| 齐河县| 临西县| 龙山县| 临夏县|